Morgan Stanley’s Arcadia Biosciences RKDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3 | Hold |
2
| – | – | ﹤0.01% | 8249 |
|
|
2025
Q4 | $4 | Sell |
2
-606
| -100% | -$2.23K | ﹤0.01% | 8164 |
|
|
2025
Q3 | $2.11K | Sell |
608
-179
| -23% | -$731 | ﹤0.01% | 7294 |
|
|
2025
Q2 | $3.39K | Buy |
787
+179
| +29% | +$707 | ﹤0.01% | 7128 |
|
|
2025
Q1 | $1.81K | Buy |
608
+1
| +0.2% | +$4 | ﹤0.01% | 7193 |
|
|
2024
Q4 | $3.59K | Hold |
607
| – | – | ﹤0.01% | 7087 |
|
|
2024
Q3 | $1.66K | Hold |
607
| – | – | ﹤0.01% | 7165 |
|
|
2024
Q2 | $1.91K | Buy |
607
+400
| +193% | +$1.01K | ﹤0.01% | 7073 |
|
|
2024
Q1 | $457 | Sell |
207
-207
| -50% | -$537 | ﹤0.01% | 7246 |
|
|
2023
Q4 | $1.3K | Buy |
414
+207
| +100% | +$648 | ﹤0.01% | 7178 |
|
|
2023
Q3 | $693 | Sell |
207
-6
| -3% | -$25 | ﹤0.01% | 7273 |
|
|
2023
Q2 | $826 | Sell |
213
-5
| -2% | -$27 | ﹤0.01% | 7326 |
|
|
2023
Q1 | $1.63K | Buy |
218
+6
| +3% | +$64 | ﹤0.01% | 7275 |
|
|
2022
Q4 | $2.3K | Hold |
212
| – | – | ﹤0.01% | 7332 |
|
|
2022
Q3 | $4K | Sell |
212
-63
| -23% | -$2.15K | ﹤0.01% | 7317 |
|
|
2022
Q2 | $11K | Sell |
275
-163
| -37% | -$7.5K | ﹤0.01% | 7189 |
|
|
2022
Q1 | $24K | Sell |
438
-518
| -54% | -$24.7K | ﹤0.01% | 7075 |
|
|
2021
Q4 | $39K | Buy |
956
+16
| +2% | +$1.04K | ﹤0.01% | 6925 |
|
|
2021
Q3 | $78K | Sell |
940
-22
| -2% | -$2.06K | ﹤0.01% | 6502 |
|
|
2021
Q2 | $114K | Buy |
962
+880
| +1,073% | +$95.9K | ﹤0.01% | 6299 |
|
|
2021
Q1 | $9K | Buy |
82
+80
| +4,000% | +$9.81K | ﹤0.01% | 6984 |
|
|
2020
Q4 | $0 | Sell |
2
-25
| -93% | -$3.05K | ﹤0.01% | 7099 |
|
|
2020
Q3 | $3K | Sell |
27
-278
| -91% | -$37.5K | ﹤0.01% | 6522 |
|
|
2020
Q2 | $46K | Sell |
305
-42
| -12% | -$6.53K | ﹤0.01% | 5702 |
|
|
2020
Q1 | $40K | Buy |
347
+76
| +28% | +$13.2K | ﹤0.01% | 5556 |
|
|
2019
Q4 | $59K | Buy |
271
+215
| +384% | +$43.1K | ﹤0.01% | 5807 |
|
|
2019
Q3 | $11K | Sell |
56
-1,982
| -97% | -$380K | ﹤0.01% | 6175 |
|
|
2019
Q2 | $250K | Buy |
2,038
+2,037
| +203,700% | +$433K | ﹤0.01% | 4934 |
|
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6685 |
|
|
2018
Q4 | $0 | Sell |
1
-54
| -98% | -$9.08K | ﹤0.01% | 6708 |
|
|
2018
Q3 | $10K | Buy |
55
+54
| +5,400% | +$13.6K | ﹤0.01% | 6307 |
|
|
2018
Q2 | $0 | Buy |
+1
| New | +$546 | ﹤0.01% | 6733 |
|
|
2017
Q3 | – | Sell |
-1
| Closed | – | – | 6594 |
|
|
2017
Q2 | $0 | Buy |
+1
| New | +$558 | ﹤0.01% | 6638 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | -$1K | – | 6553 |
|
|
2016
Q2 | $1K | Buy |
+1
| New | +$1.67K | ﹤0.01% | 6440 |
|
|
2016
Q1 | – | Hold |
0
| – | -$1K | – | 6685 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | -$2.6K | – | 6574 |
|
|
2015
Q3 | $3K | Buy |
+1
| New | +$4.16K | ﹤0.01% | 6451 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6576 |
|
Other funds holding RKDA
AC
SM
VCM
VFT
TRCT
SS
Morgan Stanley's RKDA Position: Q1 2026 in Review
Morgan Stanley held its Arcadia Biosciences (RKDA) position steady in Q1 2026 at 2 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #8249.
Morgan Stanley first reported a position in RKDA in Q3 2015 and has held it in 35 quarters since. The position peaked at $250K in Q2 2019. 16 funds tracked by Wall St. Rank hold RKDA as of Q1 2026.
- Morgan Stanley held 2 shares of Arcadia Biosciences worth $3 as of Q1 2026.
- Morgan Stanley left its Arcadia Biosciences share count unchanged in Q1 2026.
- Arcadia Biosciences made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #8249 holding.
- Morgan Stanley first reported a position in Arcadia Biosciences in Q3 2015 and has held it in 35 quarters since.
- Morgan Stanley's Arcadia Biosciences position peaked at $250K in Q2 2019.
- 16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.